Monson Jonathan
- SEC CIK
- 0001779170
No open-market purchases or sales filed in the past year.
Current role at each company
- BSX Boston Scientific CorpEVP and CFOas of Aug 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Monson Jonathan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 (view filing) | Mar 31 | Same day | Monson JonathanSVP, Global Controller and CAO | SSale | −5.00K | $50.00 | −$250.0K | −12.5%34.9K after | |
| Mar 2, 2023 (view filing) | Mar 1 | 1 day | Monson JonathanSVP, Global Controller and CAO | SSale | −5.00K | $46.66 | −$233.3K | −12.5%34.9K after |